Kiniksa Pharmaceuticals International PLC logo

Kiniksa Pharmaceuticals International PLC - Class A

NEW
NAS:KNSA (UK)   Class A
$ 63.93 +2.89 (+4.73%) 11:08 PM EST
71.06
P/B:
8.09
Market Cap:
$ 4.92B
Enterprise V:
$ 4.46B
Volume:
711.66K
Avg Vol (2M):
791.12K
Trade In:
Volume:
711.66K
Avg Vol (2M):
791.12K

Business Description

Kiniksa Pharmaceuticals International PLC logo
Kiniksa Pharmaceuticals International PLC
NAICS : 325412 SIC : 2833
ISIN : GB00BRXB0C07

Share Class Description:

KNSA: Class A

Total Employee Number:

366
Description
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
Name Current Vs Industry Vs History
Cash-To-Debt
51.87
Equity-to-Asset
0.73
Debt-to-Equity
0.02
Debt-to-EBITDA
0.1
Interest Coverage
N/A
N/A
N/A
Piotroski F-Score
8/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
14.06
Distress
Grey
Safe
Beneish M-Score
-3.29
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
60.41
9-Day RSI
59.28
14-Day RSI
59.91
3-1 Month Momentum %
20.73
6-1 Month Momentum %
37.55
12-1 Month Momentum %
87.97

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
3.79
Quick Ratio
3.33
Cash Ratio
2.99
Days Inventory
51.17
Days Sales Outstanding
15.74
Days Payable
9.29

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-3.1
Shareholder Yield %
0.18

Financials (Next Earnings Date:2026-07-29 Est.)

KNSA's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:KNSA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Kiniksa Pharmaceuticals International PLC Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 754.045
EPS (TTM) ($) 0.9
Beta 0.2836
3-Year Sharpe Ratio 1.26
3-Year Sortino Ratio 3.56
Volatility % 38.59
14-Day RSI 59.91
14-Day ATR ($) 2.70587
20-Day SMA ($) 61.70075
12-1 Month Momentum % 87.97
52-Week Range ($) 26.27 - 67.53
Shares Outstanding (Mil) 76.94

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Kiniksa Pharmaceuticals International PLC Filings

Filing Date Document Date Form
No Filing Data

Kiniksa Pharmaceuticals International PLC Stock Events

Financials Calendars
Event Date Price ($)
Third quarter earnings conference call for 2026 2026-10-28 08:30 In 103 days
Third quarter earnings results for 2026 2026-10-28 In 102 days
Second quarter earnings conference call for 2026 2026-07-29 08:30 In 12 days
Second quarter earnings results for 2026 2026-07-29 In 11 days
Goldman Sachs 47th Annual Global Healthcare Conference 2026-06-09 11:20 49.04 (+0.49%)
Guidance call for 2026 2026-06-03 08:45 46.92 (-1.84%)
General meeting for 2026 2026-05-29 09:00 50.84 (-2.23%)
First quarter earnings conference call for 2026 2026-04-28 08:30 43.61 (+2.20%)
First quarter earnings results for 2026 2026-04-28 43.61 (+2.20%)
TD Cowen 46 Annual Health Care Conference 2026-03-02 15:10 44.49 (+1.44%)
Show
Entries

Kiniksa Pharmaceuticals International PLC Frequently Asked Questions

What is Kiniksa Pharmaceuticals International PLC(KNSA)'s stock price today?
The current price of KNSA is $63.93. The 52 week high of KNSA is $67.53 and 52 week low is $26.27.
When is next earnings date of Kiniksa Pharmaceuticals International PLC(KNSA)?
The next earnings date of Kiniksa Pharmaceuticals International PLC(KNSA) is 2026-07-29 Est..
Does Kiniksa Pharmaceuticals International PLC(KNSA) pay dividends? If so, how much?
Kiniksa Pharmaceuticals International PLC(KNSA) does not pay dividend.

Guru Commentaries on NAS:KNSA

No articles.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1